A
Ana Barac
Researcher at Georgetown University
Publications - 158
Citations - 8236
Ana Barac is an academic researcher from Georgetown University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 30, co-authored 126 publications receiving 5347 citations. Previous affiliations of Ana Barac include MedStar Georgetown University Hospital & MedStar Washington Hospital Center.
Papers
More filters
Journal ArticleDOI
Rare cause of intracardiac mass: epstein bar virus related cardiac lymphoma.
Journal ArticleDOI
A narrative review of heart failure with preserved ejection fraction in breast cancer survivors
Vidhushei Yogeswaran,Elena Wadden,Ana Barac,Michael S. Simon,Charles Eaton,Richard Cheng,Kerryn W. Reding +6 more
TL;DR: In this paper , the authors investigated the risk of heart failure with preserved ejection fraction (HFpEF) in breast cancer patients after breast cancer treatment and found that HFpEF is more prevalent after BC and is associated with substantial health burden.
Journal ArticleDOI
Abstract P6-05-09: Cardiovascular Risk Evaluation for Breast Cancer Survivors: A Pilot Study
Ilana Schlam,Dipanjan Debnath,Christopher Gallagher,Asma Dilawari,Shruti Rakesh Tiwari,Malate Aschalew,Hiwot Guebre-Xabiher,Stacy Malloy,Kristi D. Graves,Ana Barac,Ami Chitalia +10 more
TL;DR: Schlam et al. as mentioned in this paper described the feasibility of performing CVD risk assessment in a cohort of BC survivors in a single institution in an urban area that serves mostly Black/African American (AA) populations.
Journal ArticleDOI
Tales of the Unexpected: The Value of Case Reports in CardioOncology.
Charlotte Manisty,Ana Barac +1 more
Abstract: Corresponding Author
Journal ArticleDOI
Cardio-oncology: Implications for Clinical Practice for Women
TL;DR: This review summarizes the CV effects associated with multimodality breast cancer treatments and contemporary approach to CV risk stratification, prevention, early detection, monitoring, and management at the time of cancer diagnosis, during and after completion of treatment.